Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 12.89M | £ 28.14M | £ 10.64M | £ 9.42M | £ 13.43M |
Total Assets | £ 252.30M | £ 288.62M | £ 281.73M | £ 301.24M | £ 306.79M |
Total Debt | £ 89.04M | £ 102.31M | £ 108.11M | £ 129.24M | £ 133.50M |
Net Debt | £ 76.15M | £ 74.17M | £ 97.47M | £ 119.83M | £ 120.08M |
Total Liabilities | £ 96.56M | £ 111.42M | £ 118.14M | £ 143.41M | £ 148.42M |
Stockholders Equity | £ 155.74M | £ 177.20M | £ 163.59M | £ 157.83M | £ 158.37M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |